Study: Heartburn meds could shorten life span

Popular heartburn medications like Nexium, Prilosec or Prevacid may increase your risk of early death when taken for extended periods, a new study suggests.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news

Related Links:

By HANS DUVEFELT Leo Dufour is not a diabetic. He is in his mid 50s, a light smoker with hypertension and a known hiatal hernia. He has had occasional heartburn and has taken famotidine for a few years along with his blood pressure and cholesterol pills. Over the past few months, he started to experience a lot more heartburn, belching and bloating. Adding pantoprazole did nothing for him. I referred him to a local surgeon who did an upper endoscopy. This did not reveal much, except some retained food in his stomach. A gastric emptying study showed severe gastroparesis. The surgeon offered him a trial of metoclopra...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Medical Practice Physicians Primary Care Hans Duvefelt Source Type: blogs
Schmitz Sandy Many nitrosamines are potent carcinogens, with more than 30 listed under California’s Proposition 65. Recently, nitrosamine contamination of commonly used drugs for treatment of hypertension, heartburn, and type 2 diabetes has prompted numerous Food and Drug Administration (FDA) recalls in the US. These contaminants include the carcinogens NDMA (N-nitrosodimethylamine) and NDEA (N-nitrosodiethylamine) and the animal tumorigen NMBA (N-nitroso-N-methyl-4-aminobutyric acid). NMBA and NDEA are metabolically and/or structurally related to NDMA, an N-nitrosomethyl-n-alkylamine (NMA), and 12 other c...
Source: International Journal of Environmental Research and Public Health - Category: Environmental Health Authors: Tags: Communication Source Type: research
(Natural News) A woman from Ridgeway, Virginia, is the latest to file a lawsuit against the makers of heartburn medication Zantac, claiming that the drug gave her esophageal cancer. Deborah Haskins said that she began using Zantac in 2005, taking at least one 75mg tablet a day. She was later diagnosed with esophageal cancer, apparently due...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
HEARTBURN is a burning feeling in the chest caused by stomach acid travelling up towards the throat. In some instances, the condition could signal cancer.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Taking steps to combat acid reflux can help minimize the use of potentially dangerous drugs.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Gastroesophageal Reflux (Acid Reflux) Heartburn Content Type: Service Diet and Nutrition Obesity Weight Exercise Smoking and Tobacco Source Type: news
In the early days of the COVID-19 pandemic, doctors in Wuhan noticed something surprising. Many of the elderly patients who survived the virus were poor: not exactly the demographic you would expect to fare well in a health crisis. A review of the survivors’ medical records revealed that a significant number suffered from chronic heartburn and were taking an inexpensive drug called famotidine, the key ingredient in Pepcid.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
This study investigated the effect of sodium alginate on biopsy-related gastrointestinal symptoms.METHODS: In this open-label, randomized, controlled trial, patients undergoing EGD with biopsy were randomly assigned to a treatment or control group. In the treatment group, sodium alginate was orally administered for 3 days after EGD. Patients completed questionnaires about their gastrointestinal symptoms at baseline (past week), the day after returning home, and after another 3 days. Gastrointestinal symptoms, including abdominal pain, epigastric pain/soreness, heartburn, acid reflux, nausea/vomiting, borborygmus, abdominal...
Source: Gut and Liver - Category: Gastroenterology Authors: Source Type: research
This study aims to investigate the clinical significance of IEM in CCv4.0 in the context of gastroesophageal reflux disease (GERD).MethodsA retrospective study was conducted among suspected GERD patients who had heartburn and/or regurgitation as their chief complaints and completed esophageal function tests in our center from 2017 to 2019. Patients were further grouped as “CCv3.0 IEM” and normal motility according to Chicago Classification version 3.0 (CCv3.0), and as “CCv4.0 IEM” and normal motility according to CCv4.0. The clinical characteristics, high-resolution manometry, esophageal reflux moni...
Source: Esophagus - Category: Gastroenterology Source Type: research
Chest. 2021 Aug;160(2):e195-e198. doi: 10.1016/j.chest.2021.02.051.ABSTRACTA 29-year-old woman who is a never smoker and has a medical history of systemic hypertension presented with a 3-week history of generalized fatigue and dry cough. She endorsed sicca symptoms of dry eyes and dry mouth. She denied breathlessness, fever, chills, night sweats, or weight loss. She had no heartburn, postnasal drip, joint pain, swelling, or skin lesions. She had no known lung disease or history of pneumothorax. Her family history was unremarkable.PMID:34366044 | DOI:10.1016/j.chest.2021.02.051
Source: Chest - Category: Respiratory Medicine Authors: Source Type: research
Conclusions: Our study supports the content validity of the new PedsQL Gastroparesis Symptoms Module. The Module field test study will be conducted in a multisite national study.
Source: Journal of Pediatric Gastroenterology and Nutrition - Category: Gastroenterology Tags: Original Articles: Gastroenterology Source Type: research
More News: Esomeprazole | Health | Heartburn | Lansoprazole | Nexium | Omeprazole | Prevacid | Prilosec | Study